![Milestone Pharmaceuticals Inc. Website Screenshot](https://storage.googleapis.com/wmc-assets-37ed7b3aea0e5732/UsersData/publicpages/id-3730-date-2020-08-03.png)
http://www.milestonepharma.com
Milestone Pharmaceuticals Inc. Company Intro
Milestone aims to provide a sense of security to patients with PSVT and other episodic cardiovascular conditions through its investigational therapies.
Industry
Healthcare
Milestone Pharmaceuticals Inc. Headquaters
1111 Dr. Frederik-Philips Boulevard
Montreal,H4M 2X6
Canada
Milestone Pharmaceuticals Inc. Share price
17 May 2023 13:32 GMT
$4.1600
0.24 (6.12 %)
Milestone Pharmaceuticals Inc. Market cap
$131.763 M
WMC RANKING
2024
Milestone Pharmaceuticals Inc. # 397
BiotechnologyLatest Milestone Pharmaceuticals Inc. News
12 Feb 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners ...
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced.
12 Feb 2024
NRx Secures $5 Million Milestone Payment for Development of New Suicidal Bipolar Depression Treatments:
Advancing Treatment for Suicidal Bipolar Depression: NRx Pharmaceuticals, Inc. Receives $5 Million Milestone Payment. NASDAQ; NRXP $NRXP.
12 Feb 2024
NRx Pharmaceuticals riceve un pagamento miliare di 5 milioni di dollari Di Investing.com
RADNOR, Pa. - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), azienda biofarmaceutica in fase clinica, ha ricevuto un pagamento di 5 milioni di dollari come...
WMC Market Score
WMC Market to Revenue Score
Milestone Pharmaceuticals Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Milestone Pharmaceuticals Inc. | USD | $0 | $46,546 | $-46,138 | $1,318M | 397 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Milestone Pharmaceuticals Inc. Social Followers vs Top 4 Industry Competitors
Milestone Pharmaceuticals Inc. Post vs Top 4 Industry Competitors
Milestone Pharmaceuticals Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Milestone Pharmaceuticals Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Milestone Pharmaceuticals Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Milestone Pharmaceuticals Inc. | 0 | 1.36 | 0.05 | 0 | 0 | 0 | 0.50 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge